GBCS (Selectis Health) ROCE %: 299.46% (As of Mar. 2026)


GBCS Selectis Health Inc GBCS
45 GF Score
Price $5.25
GF Value $2.14
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Selectis Health ROCE %?

Selectis Health GBCS -2.78% 45 ROCE % is 299.46% as of Mar. 2026. GuruFocus rates GBCS with a GF Score™ of 45/100 and a GF Value™ of $2.14 (Significantly Overvalued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Selectis Health's annualized ROCE % for the quarter that ended in Mar. 2026 was 299.46%.

Selectis Health  (OTCPK:GBCS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Selectis Health ROCE % Related Terms

Selectis Health ROCE % Historical Data

* Premium members only.

The historical data trend for Selectis Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Selectis Health ROCE % Chart

Selectis Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.89 -0.47 -6.18 -2.07 6.73

Selectis Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.37 -2.58 30.21 -2.01 299.46
GBCS
45GF Score
Selectis Health Inc GBCS
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Selectis Health ROCE % Calculation

Selectis Health's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=0.711/( ( (33.447 - 19.627) + (32.578 - 25.274) )/ 2 )
=0.711/( (13.82+7.304)/ 2 )
=0.711/10.562
=6.73 %

Selectis Health's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=31.44/( ( (32.578 - 25.274) + (30.012 - 16.318) )/ 2 )
=31.44/( ( 7.304 + 13.694 )/ 2 )
=31.44/10.499
=299.46 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 299.46% mean?
Selectis Health (GBCS) has a ROCE % of 299.46% as of Mar. 2026.
Is Selectis Health's ROCE % too high?
Selectis Health's current ROCE % is 299.46%. The Healthcare Providers & Services industry median ROCE % is 6.41. Selectis Health's value of 299.46% is 4571.8% above this industry median. Overall, Selectis Health has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Selectis Health's ROCE % compare to AMS and BICX?
Selectis Health's ROCE % of 299.46% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. Selectis Health's value of 299.46% is 4571.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Selectis Health's current ROCE % of 299.46% is 4571.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Selectis Health's current ROCE % is 299.46%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selectis Health stock overvalued right now?
Based on GuruFocus' analysis, Selectis Health (GBCS) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.14, compared to a current price of $5.25 — trading 145.3% above its estimated fair value. The current ROCE % is 299.46% and 4571.8% above the Healthcare Providers & Services industry median of 6.41. Selectis Health's overall GF Score™ is 45/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Selectis Health (GBCS), the current ROCE % is 299.46% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Selectis Health (GBCS) Overvalued in 2026?

Based on GuruFocus' analysis, Selectis Health stock appears to be overvalued. The current stock price of $5.25 is trading 145.3% above its estimated GF Value™ of $2.14. GuruFocus considers Selectis Health to be Significantly Overvalued.

Key valuation signals for GBCS:

  • ROCE %: 299.46%
  • GF Value™: $2.14 vs. price of $5.25 (145.3% above fair value)
  • GF Score™: 45/100 with 4 warning signs
  • Industry Position: 4571.8% above the Healthcare Providers & Services median

No single metric tells the full story. See the GBCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Selectis Health Business Description

Address 600 17th Street, Suite 284, Denver, CO, USA, 80202
Selectis Health Inc owns and operates medical care facilities in the healthcare industry. The company acquires, develops, leases, and manages healthcare real estate and provides healthcare operations through its wholly-owned subsidiaries. The portfolio is comprised of investments in the following healthcare operations: (i) senior housing (including independent and assisted living) and (ii) post-acute/skilled nursing. It makes investments within the healthcare operations using the following six investment products: (i) direct ownership of properties, (ii) debt investments, (iii) developments and redevelopments, (iv) investment management, (v) the Housing and Economic Recovery Act of 2008, which represents investments in senior housing operations, and (vi) owning healthcare operations.
45GF Score

Get the complete analysis for GBCS

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.25
Price
$2.14
GF Value